| NCT06643884 | Suprachoroidal Administration in Subjects With Metastases to the Choroid | RECRUITING | PHASE2 | 2024-12-16 | 2027-02-28 | 2026-03-31 |
| NCT06007690 | A Phase 3 Randomized, Masked, Controlled Trial to Evaluate Efficacy and Safety of Belzupacap Sarotalocan (AU-011) Treatment Compared to Sham Control in Subjects With Primary Indeterminate Lesions or Small Choroidal Melanoma | RECRUITING | PHASE3 | 2023-12-06 | 2027-03-01 | 2026-03-01 |
| NCT05483868 | A Phase 1, Open-label Trial of Belzupacap Sarotalocan (AU-011) in Bladder Cancer | RECRUITING | PHASE1 | 2022-09-26 | 2027-04 | 2026-12 |
| NCT04417530 | Phase 2 Trial to Evaluate Belzupacap Sarotalocan (AU-011) Via Suprachoroidal Administration in Subjects With Primary Indeterminate Lesions and Small Choroidal Melanoma | COMPLETED | PHASE2 | 2020-08-05 | 2024-04-22 | 2024-04-22 |
| NCT03052127 | Study in Subjects With Small Primary Choroidal Melanoma | COMPLETED | PHASE1, PHASE2 | 2017-02-27 | 2021-01-26 | 2021-01-26 |